K-numberK260365
Device nameMammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Control Module; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Disposable Probe, 8 gauge; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Disposable Targeting Set, 8 gauge; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Foot Switch; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Reusable Tray; Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Battery Char
ApplicantDevicor Medical Products, Inc.
Product codeKNW
Device classClass II
Decision dateMar 4, 2026
DecisionSubstantially Equivalent
Regulation876.1075
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System is a battery-operated, MRI-guided minimally invasive device designed to acquire breast tissue samples from imaged abnormalities for histologic examination. It uses vacuum and radial cutting functions to collect diagnostic tissue specimens, with both reusable components (control module, batteries, foot switch) and sterile disposable components (probe, targeting set, vacuum canister).

Technological characteristics

Both the subject device and predicate (Mammotome MR Biopsy System K042753) use stainless steel cutting elements, facilitate tissue removal through vacuum and radial cutting, and employ similar probe and targeting set designs. Key differences include automatic specimen retrieval in a basket (subject) versus manual removal with forceps (predicate), use of PEEK material in subject versus Liquid Crystal Polymer in predicate, and operation inside the MR procedure room (subject) versus outside (predicate).

Test standards cited

ASTM F2213-17 (magnetically-induced torque), ASTM F2182-19e2 (RF-induced heating), ASTM F2503-23e1 (MR safety), IEC 60601-1, IEC 60601-2-2, IEC 60601-1-6, IEC 60601-1-2 (electrical safety and EMC), ISO 10993 series (biocompatibility including cytotoxicity, sensitization, pyrogenicity, and irritation).

Substantial equivalence argument

The subject device has the same general intended use, similar indications for use, and identical core technological principles (MR-guided vacuum-assisted breast biopsy with stainless steel cutting elements) as the predicate. Performance testing demonstrates equivalent sample acquisition, sample quality rated as excellent diagnostic quality, and successful meeting of all bench and animal testing criteria, supporting that design differences do not raise new safety or effectiveness questions.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →